Want to see SE:SLEEP full AI Analyst Report?
Top Page
Sleep Cycle AB
(SLEEP)
Select Model
Select Model
Rating:72Outperform
Price Target:
kr27.00
▲(8.00% Upside)
Action:Upgraded
Date:05/12/26
The score is driven primarily by strong financial quality—high profitability and low leverage—tempered by slowing/negative recent revenue growth and a notable step-down in free cash flow. Technical signals are mixed (negative MACD with neutral RSI despite price above moving averages), while valuation is reasonable with a mid P/E and moderate dividend yield.
Positive Factors
High profitability margins
Sustained high gross and operating margins indicate durable unit economics and pricing power for the app business. Strong margins support reinvestment in product, marketing, and R&D while cushioning earnings through slower top-line periods, aiding long-term profitability sustainability.
Negative Factors
Declining revenue growth
Negative trailing revenue growth suggests weakening demand or saturation in core markets. Persistent top-line decline constrains the company’s ability to leverage fixed costs, limits reinvestment capacity, and increases reliance on retention/monetization to sustain absolute profits over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
High profitability margins
Sustained high gross and operating margins indicate durable unit economics and pricing power for the app business. Strong margins support reinvestment in product, marketing, and R&D while cushioning earnings through slower top-line periods, aiding long-term profitability sustainability.
Read all positive factors
Sleep Cycle AB (SLEEP) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr504.91M
Dividend Yield2.13%
Average Volume (3M)46.23K
Price to Earnings (P/E)11.3
Beta (1Y)0.10
Revenue Growth-10.44%
EPS Growth-30.79%
CountrySE
Employees40
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)2.21
Shares Outstanding20,277,563
10 Day Avg. Volume28,513
30 Day Avg. Volume46,232
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)7.24
Price to Sales (P/S)2.10
P/FCF Ratio9.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.88
Revenue Forecast (FY)kr220.60M
Sleep Cycle AB Business Overview & Revenue Model
Company Description
Founded in 2001 and headquartered in Gothenburg, Sweden, Sleep Cycle AB (publ) specializes in providing applications for sleep monitoring. The company also engineers various devices designed to track both sleep and general health. Its flagship off...
How the Company Makes Money
Sleep Cycle primarily makes money by monetizing its Sleep Cycle mobile app through paid subscriptions. Users can download and use a free version with limited functionality, while advanced features are offered via recurring subscription plans (typi...
Sleep Cycle AB Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 238.58M | 247.88M | 261.53M | 236.15M | 213.27M | 182.94M |
| Gross Profit | 89.58M | 121.36M | 201.87M | 128.55M | 156.65M | 141.62M |
| EBITDA | 63.40M | 73.62M | 88.45M | 64.05M | 46.27M | 12.37M |
| Net Income | 44.92M | 53.21M | 62.64M | 46.14M | 33.94M | 8.11M |
Balance Sheet | ||||||
| Total Assets | 207.07M | 200.15M | 236.49M | 230.54M | 301.37M | 227.76M |
| Cash, Cash Equivalents and Short-Term Investments | 115.27M | 120.85M | 144.82M | 133.47M | 232.86M | 165.51M |
| Total Debt | 6.60M | 7.38M | 11.74M | 15.92M | 4.20M | 2.49M |
| Total Liabilities | 129.73M | 128.31M | 157.04M | 169.55M | 140.54M | 118.86M |
| Stockholders Equity | 77.34M | 71.83M | 79.46M | 61.00M | 160.83M | 108.90M |
Cash Flow | ||||||
| Free Cash Flow | 28.40M | 52.88M | 59.73M | 51.00M | 53.76M | 14.15M |
| Operating Cash Flow | 43.40M | 52.93M | 63.66M | 52.72M | 61.53M | 20.09M |
| Investing Cash Flow | -21.33M | -13.15M | -3.92M | -6.81M | -7.77M | -5.93M |
| Financing Cash Flow | -63.90M | -64.19M | -48.36M | -145.30M | 14.01M | 98.22M |
Sleep Cycle AB Technical Analysis
Neutral
25.00
Price Trends
24.63
Negative
21.56
Positive
21.53
Positive
Market Momentum
0.11
Positive
46.70
Neutral
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SLEEP, the sentiment is Neutral. The current price of 25 is above the 20-day moving average (MA) of 24.69, above the 50-day MA of 24.63, and above the 200-day MA of 21.53, indicating a neutral trend. The MACD of 0.11 indicates Positive momentum. The RSI at 46.70 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:SLEEP.
Sleep Cycle AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | kr471.40M | 15.22 | ― | 3.48% | 4.84% | 5.70% | |
72 Outperform | kr504.91M | 11.27 | 70.05% | 7.64% | -10.44% | -30.79% | |
69 Neutral | kr70.92M | 20.77 | ― | ― | -0.22% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | kr82.92M | -0.59 | -101.81% | ― | -12.80% | -461.92% | |
45 Neutral | kr148.07M | -1.15 | ― | ― | -19.34% | -1.24% | |
43 Neutral | kr25.29M | -0.46 | ― | ― | -40.96% | -813.82% |
* Technology Sector Average
SE:SLEEP
Sleep Cycle AB
24.50
-5.68
-18.81%
SE:CHECK
Checkin.com Group AB
2.52
-5.36
-68.02%
SE:FLOWS
Flowscape Technology AB
3.46
0.35
11.25%
SE:GENI
Generic Sweden AB
39.00
-12.04
-23.60%
SE:MOBA
M.O.B.A. Network AB
1.03
-4.78
-82.33%
SE:BUSER
Bambuser AB
17.70
-3.15
-15.11%
Sleep Cycle AB Corporate Events
Sleep Cycle partners with Ant Group to expand AI sleep tech into China
Jul 23, 2026
Sleep Cycle has signed an AI-powered SDK licensing agreement with Ant Group, operator of China’s Alipay platform, to integrate its proprietary audio-based sleep analysis technology into Ant’s digital health services under a one-year pi...
Sleep Cycle Calls EGM as New Majority Owner Reshapes Board and Fees
Jul 10, 2026
Sleep Cycle AB has called an extraordinary general meeting in Stockholm on 5 August 2026, following Snark BidCo AB’s completion of its offer and acquisition of 78.2 percent of the company’s shares and votes. The meeting will handle for...
Sleep Cycle seals Ultrahuman SDK deal to scale ‘Powered by Sleep Cycle’ strategy
Jul 3, 2026
Sleep Cycle has signed a commercial software licensing agreement with global health and wearable technology company Ultrahuman, formalizing and extending a pilot that began in November 2025. The deal allows Ultrahuman to continue integrating Sleep...
Sleep Cycle Board Rejects Altor’s Takeover Bid as Undervaluing Growth Potential
May 22, 2026
Sleep Cycle’s independent board members have unanimously advised shareholders to reject a SEK 24.50 per share cash takeover bid from Altor-controlled Snark BidCo, valuing the company at about SEK 497 million and offering a near 50% premium t...
Sleep Cycle Board Weighs Altor-Backed Takeover Offer
May 11, 2026
Sleep Cycle AB’s board is assessing a public cash takeover offer from Snark BidCo AB, an Altor-controlled vehicle, to acquire all outstanding shares at SEK 24.50 per share, following a period of prior contact and limited due diligence. The b...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.